La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Valley Ntl a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Valley Ntl..

Valley Ntl (NASDAQ:VLYPP) Azioni, Catena delle Opzioni

Valley Ntl

Valley National Bancorp is a bank holding company whose principal wholly-owned subsidiary is Valley National Bank. It provides a full range of commercial, retail, and trust and investment services largely through its offices and ATM network throughout northern and central New Jersey, New York City Long Island, Florida, and Alabama. The segments of the group are commercial lending, consumer lending, investment management, and corporate and other adjustments, of which key interest income is derived from the commercial lending segment. In recent years, the company has focused on acquiring companies that operate outside of traditional banking and has emphasized wealth and capital management.

Valley National Bancorp - 6.25% Fixed-to-Floating Rate Series A Non-Cumulative Perpetual Preferred Stock

Valley National Bancorp

Evercore ISI Group analyst James West downgrades Valaris (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VAL#NYSE">VAL</a>) from Outperform to In-Line and lowers the price target from $87 to $59.

News

Downgrades

Price Target

Analyst Ratings

Evercore ISI Group Downgrades Valaris to In-Line, Lowers Price Target to $59

Wells Fargo CFO Says The Consumer Continues To Be Strong

Cantor Fitzgerald analyst Kristen Kluska reiterates Amicus Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOLD#NASDAQ">FOLD</a>) with a Overweight and maintains $21 price target.

Reiteration

FOLD

Cantor Fitzgerald Reiterates Overweight on Amicus Therapeutics, Maintains $21 Price Target

Evercore ISI Group analyst James West downgrades Transocean (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RIG#NYSE">RIG</a>) from Outperform to In-Line and lowers the price target from $6 to $5.

Evercore ISI Group Downgrades Transocean to In-Line, Lowers Price Target to $5

Cantor Fitzgerald analyst Kristen Kluska maintains PTC Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTCT#NASDAQ">PTCT</a>) with a Overweight and lowers the price target from $80 to $76.

PTCT

Cantor Fitzgerald Maintains Overweight on PTC Therapeutics, Lowers Price Target to $76

Canaccord Genuity analyst Austin Moeller maintains Bridger Aerospace Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BAER#NASDAQ">BAER</a>) with a Buy and maintains $6 price target.

BAER

Canaccord Genuity Maintains Buy on Bridger Aerospace Gr, Maintains $6 Price Target

Cantor Fitzgerald analyst Brett Knoblauch maintains Applied Digital (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) with a Overweight and lowers the price target from $15 to $14.

APLD

Cantor Fitzgerald Maintains Overweight on Applied Digital, Lowers Price Target to $14

Evercore ISI Group analyst James West downgrades Noble Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NE#NYSE">NE</a>) from Outperform to In-Line and lowers the price target from $64 to $41.

Evercore ISI Group Downgrades Noble Corp to In-Line, Lowers Price Target to $41

OS Therapies reiterates clinical and regulatory path in recurrent, fully respected osteosarcoma with lung metastases, an indication with no currently approved treatments.
 &nbsp;

OSTX

OS Therapies Says Phase 2b Clinical Trial Of OST-HER2 Achieves Primary Endpoint With Statistical Significance In Prevention Of Recurrent, Fully Resected, Lung Metastatic Osteosarcoma

Interview

BlackRock CEO Larry Fink Says Don't Believe You'll See BlackRock In The Market Buying Whole Companies

Evercore ISI Group analyst James West downgrades Helmerich &amp; Payne (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HP#NYSE">HP</a>) from Outperform to In-Line and lowers the price target from $48 to $39.

Evercore ISI Group Downgrades Helmerich & Payne to In-Line, Lowers Price Target to $39

WIIM

Bank of New York Mellon shares are trading higher following better-than-expected Q4 financial results.

SPRC

SciSparc Says It Is Granted 180-Day Extension Until July 14, 2025, By Nasdaq To Regain Compliance With Minimum Bid Requirement

GS: 3% &#x7C; <a href="https://www.benzinga.com//node/42999133">Goldman Sachs Q4 Investment Banking Fees Rose 24% YoY, Global Banking &amp; Markets Revenue Rose 33%, Provision For Credit Losses Fell 39%</a>
&nbsp;
VCEL: -12% &#x7C; <a href="https://www.benzinga.com//node/42997435">Vericel shares are trading lower after the company issued preliminary FY24 and Q4 net revenue below estimates.</a>
&nbsp;
COMP: 11% &#x7C; <a href="https://www.benzinga.com//node/42998131">Compass shares are trading higher after the company raised its Q4 and FY24 guidance.</a>

Movers

Trading Ideas

COMP

VCEL

Market-Moving News for January 15th

AVXL

Anavex Life Sciences Reveals Peer-reviewed Publication Of Oral Blarcamesine Phase IIb/III Data In Journal Of Prevention Of Alzheimer's Disease

Seaport Global analyst Kenneth Zener upgrades KB Home (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBH#NYSE">KBH</a>) from Sell to Neutral.

Upgrades

Seaport Global Upgrades KB Home to Neutral

Prairie expects Average Daily Production: 7,000 – 8,000 barrels of oil equivalent per day (BOEPD), representing a ~300% increase year-over-year.
Prairie plans to actively pursue additional strategic acquisition opportunities, the completion of which will result in an update to guidance to reflect the enhanced scale and value of the Company.

Guidance

PROP

Prairie Operating Expects 2025 Net Income  Of $69M - $102M, Adjusted EBITDA Of $100M - $140M,

Earnings

Goldman Sachs Total Loans Increased 7% During The Year

QBTS

D-wave Quantum Inks Pact With Carahsoft Partner To Expand Distribution Of Quantum Computing Solutions To The Public Sector

Rosenblatt analyst Blair Abernethy maintains Silvaco Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SVCO#NASDAQ">SVCO</a>) with a Buy and maintains $18 price target.

SVCO

Rosenblatt Maintains Buy on Silvaco Group, Maintains $18 Price Target

Valley National Bancorp 6.25% PFD SER Ap goes ex dividend tomorrow

Valley National Bancorp (VLY) Q1 2024 Earnings Call Transcript

Valley National: Risk Keeps Me Sidelined From High Yielding Preferred Shares

Valley National Bancorp (VLY) Q2 2024 Earnings Call Transcript

Valley National Bancorp 6.25% PFD SER Ap declares $0.39 dividend

New Preferred Stock And Exchange Traded Debt IPOs, August 2024

Preferreds Weekly Review: Recent Issues Often Offer Highest Yields

Valley National Bancorp: Still Avoiding Preferred Shares Despite Better Earnings

Valley National Bancorp 6.25% PFD SER Ap declares $0.3906 dividend

AOMN

AOMR

CCIA

CCIF

CIMN

CIMO

VLYPN

VLYPO

VLYPP

BOK Financial

Cadence Bank

Commerce Bancshares

Citizens Financial Group, Inc. Common Stock

Citizens Financial Group

Cullen/Frost Bankers

Columbia Banking System, Inc. - Common Stock

Columbia Banking System

East West Bancorp

First Horizon

F N B

Glacier Bancorp

Huntington Bancshares Incorporated - Common Stock

Huntington Bancshares

Home BancShares

M&T Bank

Old National

Prosperity Bancshares

Pinnacle Financial Partners, Inc. - Common Stock

Pinnacle Finl Partners

Regions Financial Corporation Common Stock

Regions Finl

Synovus Finl

SouthState

Truist Financial Corporation Common Stock

Truist Finl

UMB Financial

Western Alliance Bancorporation Common Stock (DE)

Western Alliance

Webster Financial Corporation Common Stock

Webster Finl

Wintrust Financial Corporation - Common Stock

Comments

Valley Ntl

Valley Ntl (VLYPP) Opzioni

No option chain data available. Please try again later

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO